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We have reconstituted a highly purified RNA
polymerase II transcription system containing
chromatin templates assembled with purified
histones and assembly factors, the histone ace-
tyltransferasep300, and components of the gen-
eral transcriptionmachinery that, by themselves,
suffice for activated transcription (initiation and
elongation) on DNA templates. We show that
this systemmediates activator-dependent initia-
tion, but notproductiveelongation, onchromatin
templates. We further report the purification
of a chromatin transcription-enabling activity
(CTEA) that, in a manner dependent upon p300
and acetyl-CoA, strongly potentiates transcrip-
tion elongation through several contiguous
nucleosomes as must occur in vivo. The tran-
scription elongation factor SII is amajor compo-
nent of CTEA and strongly synergizes with p300
(histone acetylation) at a step subsequent to
preinitiation complex formation. The purifica-
tion of CTEA also identified HMGB2 as a coacti-
vator that, while inactive on its own, enhances
SII and p300 functions.
INTRODUCTION
In living cells, RNA polymerase II must efficiently tran-
scribe DNA within a nucleosomal (chromatin) context,
and several distinct transcriptional machineries have
been implicated in this process. The general machinery
that is necessary and sufficient for basal (core promoter-
mediated) transcription from purified DNA templates con-
sists of RNA polymerase II and the general initiation fac-
tors (GTFs) TFIIA, TFIIB, TFIID, TFIIE, TFIIF, and TFIIH
(Orphanides et al., 1996; Roeder, 1996). Efficient activa-
tor-dependent transcription from DNA templates in puri-
fied systems requires, in addition, a circa 30 subunit
Mediator complex that is viewed as the main conduit forcommunication between DNA bound regulatory proteins
and the general transcription machinery (Malik and
Roeder, 2000).
Subsequent to demonstrations that the nucleosomal
packaging of DNA effectively blocks basal (activator-inde-
pendent) transcription from DNA templates both in vitro
(Knezetic and Luse, 1986; Lorch et al., 1987; Workman
and Roeder, 1987) and in vivo (Han and Grunstein,
1988), a number of factors that facilitate activator-depen-
dent transcription through chromatin modifications (both
in vitro and in vivo) have been described. These cofactors
include ATP-dependent chromatin remodeling factors
(Neely andWorkman, 2002) and factors that effect histone
modifications such as acetylation, methylation, and ubiq-
uitination (Vaquero et al., 2003). Whereas the intracellular
functions of these factors in gene regulation have been
demonstrated by various genetic andmolecular biological
assays, early in vitro studies using HeLa nuclear extracts
as a source of the general transcriptional machineries
and various cofactors showed that in vitro-reconstituted
chromatin templates can be transcribed efficiently in
a manner that is dependent on the presence of an activa-
tor, an ATP-dependent remodeling activity, and covalent
histone modifications effected by histone acetyltrans-
ferases (Dilworth et al., 2000; Kraus and Kadonaga,
1998; Kundu et al., 2000; Mizuguchi et al., 2001; Neely
et al., 1999; Utley et al., 1998). Together with other ad-
vances (below), the in vitro studies with purified DNA tem-
plates and purified factors and the in vitro studies with
chromatin templates and crude transcription systems
(nuclear extracts) set the stage for a more definitive bio-
chemical analysis, through establishment of a fully defined
system, for identification of other factors that might be
involved in transcription of chromatin.
A notable advance in the studies of chromatin-tem-
plated transcription was the development (Ito et al.,
1999) of methods to assemble chromatin with purified his-
tones, recombinant assembly factors (ATP-dependent
chromatin remodeling factors and histone chaperones),
and DNA—thus eliminating possible contributions to tran-
scription of unknown factors in the crude extracts com-
monly used to assemble chromatin (Becker and Wu, 1992).Cell 125, 275–286, April 21, 2006 ª2006 Elsevier Inc. 275
Until now, however, most studies utilizing chromatin tem-
plates assembled with purified histones and recombinant
assembly factors (NAP1 chaperone and ATP-dependent
ACF complex [Ito et al., 1999]) have utilized unfractionated
HeLa or Drosophila extracts as a source of transcription
factors (An et al., 2002; Jiang et al., 2000; Levenstein and
Kadonaga, 2002). Other studies using various sources
of RNA polymerase II and GTF preparations (either
purified or partially purified) in conjunction with various
sources of chromatin templates (assembled either with
crude Drosophila extract or with recombinant assembly
factors) have led to the identification of several factors
(such as FACT, RSF, PBAF, and TAF-I/SET/INHAT) that
facilitate chromatin-templated transcription (Gamble
et al., 2005; Lemon et al., 2001; LeRoy et al., 1998; Orpha-
nides et al., 1998). FACT and TAF-I/SET/INHAT have his-
tone chaperone activities, whereas PBAF is a member of
the SWI/SNF family of ATP-dependent remodeling com-
plexes and RSF is an ISWI-containing complex. SWI/
SNF and ISWI-containing complexes have also been
shown to play roles in chromatin transcription activation
both in vivo and in vitro (Neely and Workman, 2002). Of
the above-described factors, only FACT has been shown
to work at the elongation step by overcoming a nucleo-
some-imposed transcription block that, somewhat sur-
prisingly in view of later studies (below), was not affected
by elongation factors TFIIF or TFIIS (SII) alone or in con-
junction with FACT (Orphanides et al., 1998). Earlier in vitro
studies using chromatin templates assembled with puri-
fied elongation complexes and oocyte extracts showed
that SII and TFIIF help slightly in relieving this block (Izban
and Luse, 1992). Consistent with the latter report, a recent
study with an artificially reconstituted yeast RNA polymer-
ase II elongation complex on a DNA fragment containing
a single nucleosome did report SII-dependent disruption
of the nucleosome (Kireeva et al., 2005). Notably, how-
ever, the in vitro SII study did not necessarily show a spe-
cific role for SII since it did not analyze the effect of other
elongation factors in this artificial system. Furthermore,
the SII study did not examine the more physiological situ-
ation of activator-dependent, chromatin remodeling-de-
pendent, and histone modification-dependent transcrip-
tion from nucleosomal array templates.
Because the previous biochemical studies of factors in-
volved in chromatin transcription utilized reconstituted
transcription systems of varying purity or systems that op-
erated independently of histone modifications, they have
led to the description of several different factors that act
through different mechanisms. To define the minimal
complement of factors necessary for this process, we
have used chromatin templates assembled with pure his-
tones and recombinant assembly factors, recombinant
activators and coactivators, and a transcription assay sys-
tem reconstituted with highly purified factors to identify, in
HeLa nuclear extract, an activity (CTEA) that is dispens-
able for activator-dependent transcription from DNA tem-
plates but essential for productive activator-dependent
transcription elongation from chromatin templates in con-276 Cell 125, 275–286, April 21, 2006 ª2006 Elsevier Inc.junction with ATP-dependent chromatin remodeling and
histone acetyltransferase activities. We have purified
CTEA activity and reconstituted its major components.
RESULTS
Assembly of a Defined Chromatin Template
and Transcription System
An initial objective of our study was to reconstitute a tran-
scription assay system with highly purified factors shown
previously to be necessary and sufficient for optimal
activator-dependent transcription from DNA templates
(Experimental Procedures). The TFIIA (p55 and p12 sub-
units), TFIIB, TFIIE (a and b subunits), and TFIIF (RAP30
and RAP74) components of the general transcription ma-
chinery, as well as the general coactivator PC4, were
expressed in and purified from bacteria (Guermah et al.,
2001). Themultisubunit TFIID, TFIIH, and RNApolymerase
II components of the general transcription machinery, as
well as the TRAP/Mediator coactivator complex, were pu-
rified from cell lines expressing epitope-tagged subunits
by combinations of conventional chromatography and
affinity purification (anti-FLAG M2 agarose) methods
(Experimental Procedures; Ge et al., 2002; Guermah
et al., 2001). These procedures provided essentially ho-
mogenous preparations of these components as shown
by SDS-PAGE with Coomassie blue and silver staining
(Figures 1A and 1B, respectively).
For chromatin assembly and functional analyses, HeLa
core histone octamers were purified from nuclear pellets,
mouse NAP1was expressed in and purified from bacteria,
and recombinant Acf-1, ISWI, Topoisomerase 1 (Topo 1),
and p300 were expressed in and purified from Sf9 cells
(Figure 1C). Chromatinwas then assembled froma relaxed
pG5MLD53 DNA template and core histones using Acf-1,
ISWI, NAP1, and Topo 1 as described (An et al., 2002; Ito
et al., 1999). The pG5MLD53 plasmid contains the adeno-
virus (Ad) major late (ML) core promoter flanked by five
GAL4 binding sites in the upstream end and a 390 nucleo-
tide G-less cassette in the downstream side (Kundu
et al., 2000). A DNA supercoiling assay showed extensive
DNA supercoiling upon chromatin assembly (data not
shown) and micrococcal nuclease (MNase) digestion re-
vealed a pattern of at least 10–12 well-resolved and regu-
larly spaced bands (Figure 1D), thus indicating complete
assembly of chromatin with regularly spaced nucleo-
somes.
Identification, Purification, and Characterization
of CTEA, an Activity that Supports Efficient
Transcription of Chromatin Templates
with the Purified System
An initial test of the suitability of the reconstituted template
for further studies showed activator- and p300 plus acetyl-
CoA-dependent transcription when HeLa nuclear extract
was employed as a source of the general transcriptional
machinery (Figure 2A). The activator (GAL4p65) used in
this assay contains the activation domain of NF-kB p65
Figure 1. Analysis of Purified Recombi-
nant GTFs, Affinity-Purified Complexes,
Chromatin Assembly Factors, and In Vi-
tro-Assembled Chromatin
(A) TFIIA (p55 and p12 subunits), TFIIB, TFIIE
(a and b subunits), and TFIIF.
(B) TFIIH, Mediator, TFIID, and RNA polymer-
ase II. Proteins were resolved on SDS-PAGE
and visualized by Coomassie blue staining in
(A) and silver staining in (B).
(C) HeLa histones, p300, NAP1, Acf1, ISWI,
and Topo 1. Proteins were resolved on SDS-
PAGE and visualized by Coomassie blue stain-
ing. In (A)–(C), relevant bars on the left indicate
protein markers from to top to bottom, in kDa:
200, 116, 97, 66, 45, 31, 21, 14, and 8.
(D) MNase analysis of chromatin assembled
with components in (C). Chromatin was di-
gested and analyzed on 1.3% agarose gels
with ethidium bromide staining. A 123 bp
ladder was used as size marker (M).fused to the GAL4 DNA binding domain. These results are
consistent with earlier reports of activator- and p300 plus
acetyl-CoA-dependent transcription from chromatin tem-
plates similarly assembled with purified histones and ACF
and assayed in nuclear extracts (An et al., 2002; Kraus and
Kadonaga, 1998; Kundu et al., 2000).
The same highly purified reconstituted transcription
system described above (TFIIA, TFIIB, TFIID, TFIIE, TFIIF,
TFIIH, RNA polymerase II, PC4, and Mediator) was previ-
ously shown to mediate robust activator-dependent tran-
scription from histone-free DNA templates (Guermah
et al., 2001). Importantly, and in contrast to nuclear ex-
tract, this system failed to support activator (GAL4p65)-
and p300 plus acetyl-CoA-dependent transcription from
the reconstituted chromatin templates when the 390 nu-
cleotide transcript was monitored (Figure 2B, lane 4).
However, addition of a nuclear extract-derived phospho-
celulose (P11) 0.85 M KCl fraction, but not the P11 0.5
M KCl fraction, supported efficient activator- and p300
plus acetyl-CoA-dependent transcription of the chromatin
template (Figure 2B, lane 3 versus lane 4 and lanes 6 and 7versus lane 5). This potentially new activity in the P11 0.85
M fraction was tentatively designated chromatin tran-
scription-enabling activity or CTEA.
CTEA was then purified through the chromatographic
scheme depicted in Figure 2C, using the purified tran-
scription system in conjunction with GAL4p65 and p300
plus acetyl-CoA to monitor activity. The CTEA transcrip-
tional activity profiles for gradient elution from Mono S
and gel filtration on Superose 6 are shown in Figures 2D
and 2E, respectively. Both columns reveal relatively uni-
form elution profiles with the peak fractions (39 and 41)
on Superose 6 corresponding to a molecular size of about
100 kDa.
Silver staining of the Superose 6 fractions revealed that
the CTEA peak activity in fractions 39 and 41 strongly cor-
relates with two protein bands of 38 kDa (p38) and 50 kDa
(p50) (Figure 2F). Microsequencing of these two bands by
mass spectrometry identified p38 as human transcription
elongation factor SII and p50 as human vaccinia-related
kinase 1 (VRK1). These data are potentially significant
for both SII and VRK1. Thus, SII has been shown to beCell 125, 275–286, April 21, 2006 ª2006 Elsevier Inc. 277
Figure 2. Identification, Characterization, and Purification of CTEA Activity
(A) Chromatin transcription in HeLa nuclear extract.
(B) Chromatin transcription in the reconstituted system in the presence of a novel activity (CTEA) in the P11 0.85 M fraction.
(C) Chromatographic scheme for purification of CTEA.
(D and E) Chromatography of CTEA on Mono S (D) and Superose 6 (E). Input (In) and indicated alternate fractions were assayed for transcriptional
activity in the reconstituted system.
(F) Polypeptide composition of the Superose 6 column fractions and the Mono Q flowthrough input (In) analyzed by SDS-PAGE and silver staining.
Transcription assays in (A), (B), (D), and (E) contained the pG5MLD53 chromatin template and factor additions as indicated.involved in the reversal of arrested RNApolymerase II mol-
ecules on DNA templates (Reines et al., 1989) and to facil-
itate transit of RNA polymerase II in an artificially formed
elongation complex through a single positioned nucleo-
some (Introduction), although there has been no previous
report of a role for SII in overcoming nucleosome repres-
sion of activator-dependent or chromatin remodeling/
modification-dependent transcription. VRK1 is related to
the vaccinia virus kinase B1 (vvB1), which is essential for
the replicationof thevaccinia virusgenome (200kbp;Rem-
pel et al., 1990).278 Cell 125, 275–286, April 21, 2006 ª2006 Elsevier Inc.CTEA Works Mainly at the Elongation Step of
Transcription and Allows RNA Polymerase II to
Overcome Blocks from Several Contiguous
Nucleosomes
The CTEA-dependent transcription assays described
above monitored the synthesis of a 390 nucleotide tran-
script that requires both accurate initiation and productive
transcription elongation events through at least two nu-
cleosomes. We then used alternative assays to gain
insights into CTEA function during early steps of transcrip-
tion (initiation and early elongation events resulting in
Figure 3. Characterization of CTEA
Function
(A) Activator-dependent production of 12 and
21 nucleotide transcripts from the pG5HML-
based chromatin templates in the reconsti-
tuted system.
(B) Minimal CTEA effects on the production of
12 and 21 nucleotide transcripts from chroma-
tin templates assayed as in (A).
(C) CTEA-dependent synthesis of long tran-
scripts from the pHIV chromatin template in
nuclear extract.
(D) MNase analysis of pHIV chromatin tem-
plates; lane 1 (0.8 mU) and lane 2 (0.4 mU).
(E) CTEA-dependent transcription of the pHIV
chromatin template in the reconstituted
system.
(F) CTEA-dependent transcription of the
pG5MLD53 chromatin template by fGAL4VP16
and fGAL4p53 in the reconstituted system.formation of 12 and 21 nucleotide transcripts). To analyze
the effect of CTEA (Superose 6) on the synthesis of short
(12 and 21 nucleotide) transcripts, chromatin templates
containing pG5HM plasmids with 12 and 21 nucleotide
G-less cassettes were assayed in the reconstituted sys-
tem. First, and in the absence of CTEA, there is a strong
activator-dependent production of both 12 and 21 nucle-
otide transcripts (Figure 3A, lane 2 versus lane 1 and lane 4
versus lane 3). Furthermore, and as shown in Figure 3B,
CTEA had only a modest (<2-fold) effect on the synthesis
of these transcripts in the presence of the activator
(Figure 3B, lanes 2 and 4 versus lanes 1 and 2, respec-
tively). For the initiation step, we used an abortive initiation
assay to analyze synthesis of the first phosphodiester
bond. Consistent with only modest effects of CTEA on
the synthesis of 12 and 21 nucleotide transcripts, CTEA
similarly had only a modest, but reproducible, effect on
the initiation step (data not shown). The much greater
magnitude of the CTEA effect on synthesis of the 390
nucleotide transcript relative to 3, 12, and 21 nucleotide
products indicates that CTEA works mainly at the elonga-
tion step of transcription to overcome the nucleosome
barrier.
The transcriptionassays (describedabove) used to iden-
tify and purify CTEA produce a transcript of 390 nucleo-
tides, which corresponds to an occupancy of about two
nucleosomes. We next wanted to examine whether CTEA
can support transcription through several contiguous nu-
cleosomes as must occur in vivo. To this end, we used
a pHIV template that contains the HIV promoter and
a 400 nucleotide G-less cassette 955 bp downstream of
the transcription initiation site (Zhou and Sharp, 1995).
To first establish activator (NF-kB p50/p65 and Sp1)-
and coactivator (p300)-dependent transcription on the
chromatinized HIV template (Figure 3D), we used exoge-
nous activators and p300 in conjunction with HeLa nuclear
extract as a source of general transcription factors.
Indeed, and as expected (Pazin et al., 1996), Sp1 andNF-kB activate transcription in this assay (Figure 3C, lanes
2 and 3 versus lane 1), with the levels of activated tran-
scription obtained with NF-kB alone or a combination of
NF-kB/Sp1 being much higher than those obtained with
Sp1 alone (Figure 3C, lanes 3 and 4 versus lane 2). We
next analyzed the requirement of CTEA (Superose 6 frac-
tion) for transcription of the pHIV chromatin template in the
purified reconstituted system described above. Results
show that there is a strong dependence on CTEA activity
for transcription of the HIV promoter in the presence of
Sp1, NF-kB, or NF-kB plus Sp1 (Figure 3E, lanes 4, 5,
and6versus lanes1,2,and3, respectively). This, therefore,
shows that CTEA can support transcription by RNA poly-
merase II through several contiguous nucleosomes in
a manner that resembles in vivo situation.
Although CTEA was shown to function with GAL4p65,
NF-kB (p50/p65), and Sp1, we wished to determine if it
mediated activation by a broader range of activators.
For this purpose, we tested GAL4 fusion proteins contain-
ing the activation domains of VP16 (fGAL4VP16) and p53
(fGAL4p53) in the purified reconstituted transcription sys-
tem containing p300 and acetyl-CoA. Indeed, CTEA
strongly potentiates the transcriptional activity of both
fGAL4VP16 and fGAL4p53 from the pG5MLD53 chromatin
templates (Figure 3F, lanes 2 and 4 versus lanes 1 and 3,
respectively). These data further establish CTEA activity
as a general elongation activity that is required for acti-
vated transcription of chromatin templates.
Recombinant SII (rSII) Can Substitute for Purified
CTEA in Chromatin-Templated Transcription
To investigate the relevance to CTEA of the major compo-
nents (SII and VRK1) that copurify with CTEA activity, we
expressed and purified these proteins both from bacteria
(Figure 4A and data not shown) and from HeLa cells that
stably express epitope-tagged proteins (data not shown).
As shown in Figure 4B, using equimolar amounts of CTEA
(based on endogenous SII) and recombinant SII (rSII) fromCell 125, 275–286, April 21, 2006 ª2006 Elsevier Inc. 279
bacteria, rSII can substantially substitute for CTEA activity
(Superose 6) in supporting activator- and p300 plus ace-
tyl-CoA-dependent transcription of chromatin templates
(Figure 4B, lane 3 versus lanes 1 and 2). Further experi-
ments have shown that rSII derived from a stable HeLa
cell line also can substitute for the purified CTEA fraction
(data not shown). Additional experiments using purified
recombinant VRK1 from bacteria and HeLa cells have
failed, thus far, to show a role for VRK1 individually or in
combination with SII in the current assay (data not shown).
It remains possible, however, that a role for VRK1 in tran-
scription could become evident when other (noncore his-
tone) chromatin-associated proteins and/or chromatin-
interacting proteins are present in the assay.
Finally, additional characterization of SII protein by
Western blot analysis revealed that, in agreement with
the functional data for CTEA activity, SII is restricted to
the 0.85 M KCl fraction on P11 and to the 0.1 M KCl frac-
tion on DE52 (Figure 4C). Of potential significance, SII pro-
tein in the P11 0.85M fraction runs, on SDS-PAGE, as two
protein bands, with only the fast-migrating form present in
the purified CTEA fraction (Figure 4C).
Collective Requirement for Activator, SII, p300, and
Acetyl-CoA for Optimal Transcription of a Chromatin
Template in the Purified Reconstituted System and
Synergy of SII and p300 plus Acetyl-CoA at a Step
after Preinitiation Complex Assembly
Although an earlier experiment (Figure 2) showed a re-
quirement for p300 plus acetyl-CoA in conjunction with
the GAL4p65 activator and CTEA in chromatin transcrip-
tion, we wanted to analyze in a more complete fashion
the contribution of each of these components. These as-
says utilized recombinant SII in place of CTEA, as well
as chromatin assembled with recombinant histones that,
unlike HeLa histones, are free of covalent modifications.
As shown in Figure 5A, there is a collective requirement
of activator (lane 6 versus lane 7), SII (lane 6 versus lane
5), p300 (lane 6 versus lane 13), and acetyl-CoA (lane 6
versus lane 12) for optimal transcription of the recombi-
nant chromatin template. This coordinate dependency re-
sembles the in vivo situation where there is a requirement
for the concerted action of activators, coactivators, and
histone modifiers to achieve optimal activated transcrip-
tion. The residual activity observed with activator and SII
(Figure 5A, lane 11) in the absence of p300 and acetyl-
CoA could reflect either an incomplete nucleosome as-
sembly on a small proportion of the chromatin templates
or an intrinsic activity that might be repressed in a more
physiological chromatin state with chromatin-associated
proteins (including H1) other than nucleosomal core his-
tones.
As a control for the experiment shown in Figure 5A and
in order to show that the effects of SII, p300, and acetyl-
CoA are specific to transcription of chromatin templates,
we performed the same experiments with equimolar
amounts of the histone-free DNA template (Figure 5B). In
stark contrast to what was observed with the chromatin280 Cell 125, 275–286, April 21, 2006 ª2006 Elsevier Inc.template, activator-dependent transcription from the
DNA template (Figure 5B) showed no requirement for or
effect of either SII (lane 6 versus lane 5) or p300 plus ace-
tyl-CoA (lane 6 versus lane 11). Of note, in the absence of
acetyl-CoA, there was a significant inhibitory effect of
p300 on activated transcription that is independent of SII
(Figure 5B, lane 4 versus lane 2 and lane 12 versus lane
11). Importantly, there was a reversal of this effect by ace-
tyl-CoA (Figure 5B, lane 5 versus lane 4 and lane 6 versus
lane 12), which suggests that p300, without its substrate,
may interfere with the action of some component in the as-
say. Although the basis for this reversal by acetyl-CoA is
unknown, it may conceivably reflect an acetyl-CoA-de-
pendent p300 conformational change and/or a p300-me-
diated acetylation event that negates the inhibitory effect.
The data described above (Figure 5A) showing the col-
lective requirement for SII, activator, p300 plus acetyl-CoA
for productive transcription do not preclude the possibility
of an exclusive effect of p300 plus acetyl-CoA (and histone
acetylation) at the step of preinitiation complex formation
with no effect on elongation. To address this critical issue,
we first assembled a complete preinitiation complex with
DNA, RNA polymerase II, GTFs, PC4, Mediator, and the
activator. This was followed by chromatin assembly, acti-
vator-dependent histone modifications, and transcription
in the reconstituted system. Our results show that p300
Figure 4. Recombinant SII (rSII) Substitution for the CTEA
Fraction in Chromatin-Templated Transcription
(A) Analysis of purified recombinant SII (rSII) by SDS-PAGE and Coo-
massie blue staining.
(B) rSII substitution for CTEA in transcription from the pG5MLD53 chro-
matin template in the reconstituted system.
(C) Western blot analysis of SII protein in P11 fractions, the purified
CTEA fraction and purified rSII (left panel) and in DE52 fractions de-
rived from the P11 0.85 M fraction (right panel). Different samples
were resolved by SDS-PAGE and analyzed by Western blotting with
SII antibodies.
Figure 5. Collective Requirement for
Activator, rSII, p300, and Acetyl-CoA
(AcCoA) in Chromatin-Templated Tran-
scription
(A) Transcription from the pG5MLD53 chroma-
tin template assembled with recombinant
histones.
(B) Transcription from a histone-free DNA
pG5MLD53 template (control for [A]).
(C) Synergistic functions of SII and p300 plus
AcCoA in effecting productive transcription
from the pG5MLD53 chromatin template at
a step after preinitiation complex assembly.
All assays were in the reconstituted system
with additions as indicated.plus acetyl-CoA and SII are both required at a step after
preinitiation complex assembly for optimal transcription
of chromatin templates (Figure 5C, lane 2 versus lanes 1
and 3). This is a very significant finding since it establishes
a strong synergy between SII and histone modifications at
a postinitiation step.
HMGB2 Enhances rSII- and p300-Dependent
Chromatin Transcription from the pHIV Template
Mainly at the Level of Elongation
Although significant CTEA activity was recovered during
purification on Mono Q (Figure 2C), there was a significant
loss of overall activity relative to the input (data not
shown), and concentration of the CTEA-containing flow-
through fraction was required for activity in the transcrip-
tion assays. This could reflect, at least in part, separation
(from SII and VRK1) of other factors that potentiate SII
function. In addition, a parallel purification of CTEA activity
that was eluted from heparin-Sepharose with 0.3 M KCl
and further purified by Mono S and Superose 6, but not
Mono Q, chromatography revealed a potent CTEA activity
that correlates with SII, VRK1, and two other proteins (data
not shown). Mass spectrometric analysis identified the lat-
ter two proteins as HMGB2 and PC4.
We then complemented transcription assays containing
HIV chromatin templates (as described in Figure 3E) with
SII, recombinant PC4, and different Mono Q gradient frac-
tions. We choose the HIV template on the assumption that
the requirement for transcription through a longer array of
nucleosomes (about seven) might impose a greater re-
quirement for factors that enhance SII function. Indeed,our analysis revealed an activity, which eluted from
Mono Q at 330–350 mMKCl, that enhances SII-dependent
chromatin transcription. One fraction (44) that correlated
with this activity was analyzed by SDS-PAGE and silver
stain (Figure 6A) and contained a highly purified 29 kDa
protein (p29) that was determined by mass spectrometry
to be HMGB2. A further analysis revealed that p29/
HMGB2 can markedly (3-fold) enhance SII-dependent
transcription of the pHIV chromatin template (Figure 6B,
lanes 6 and 7 versus lanes 2 and 3, respectively). Impor-
tantly, despite its stimulatory effect in the presence of
SII, p29/HMGB2 alone is unable to substitute for SII func-
tion in chromatin transcription (Figure 6C, lane 3 versus
lanes 2 and 1).
The HMGB2 effect was observed for productive tran-
scription elongation events through at least seven nucleo-
somes. We then used assays described above to assess
a possible HMGB2 effect on early steps of transcription.
To analyze the effect of HMGB2 on the synthesis of short
(12 nucleotide) transcripts, chromatin templates contain-
ing pG5HM plasmids with 12 nucleotide G-less cassettes
were employed. First, and in the absence of HMGB2, there
was a strong activator- and p300 plus acetyl-CoA-depen-
dent production of 12 nucleotide transcripts (Figure 6D,
lane 2 versus lane 1). Furthermore, and as shown in
Figure 3B for CTEA, rSII had no effect on the synthesis of
these transcripts in the presence of the activator and
p300 plus acetyl-CoA (Figure 6D, lane 3 versus lane 2).
The further addition of HMGB2 also had no effect on the
production of 12-nucleotide transcripts (Figure 6D, lane 4
versus lane 3). Therefore, HMGB2 effects SII- and p300Cell 125, 275–286, April 21, 2006 ª2006 Elsevier Inc. 281
Figure 6. HMGB2 Enhances rSII and
p300 Plus Acetyl-CoA-Dependent Tran-
scription from the pHIV Chromatin Tem-
plate Mainly at the Level of Elongation
(A) SDS-PAGE and silver staining analysis of
a Mono Q Fraction (number 44, Figure 2C).
The 29 kDa band was identified as HMGB2.
(B) HMGB2 (Mono Q fraction 44) enhancement
of rSII-dependent transcription of the pHIV
chromatin template.
(C) Failure of HMGB2 alone to substitute for rSII
in mediating transcription of the pHIV chroma-
tin template.
(D) Lack of an HMGB2 effect on the synthesis
of 12-nucleotide transcripts from a pG5HML-
based chromatin template. All assays were in
the reconstituted systemwith additions as indi-
cated.plus acetyl-CoA-dependent chromatin transcription
mainly at the level of elongation.
DISCUSSION
In vivo transcription by RNA polymerase II takes place in
the context of chromatin. However, as demonstrated
here, a purified, reconstituted RNA polymerase II system
that suffices for activator-dependent transcription on
DNA templates is incapable of transcribing chromatin tem-
plates even in the presence of factors (the ATP-dependent
chromatin remodeler ACF and the histone acetyltransfer-
ase p300) that effect transcription of chromatin in less-pu-
rified assay systems. Using an unbiased complementation
and nuclear extract fractionation scheme, we have identi-
fied and purified an activity, CTEA, that allows for tran-
scription through chromatin templates in a manner that is
both activator and p300 plus acetyl-CoA dependent.
CTEA acts primarily at the elongation step and enables
the RNA polymerase II machinery to transcribe efficiently
through several contiguously positioned nucleosomes.
The major functional component of CTEA is transcription
elongation factor SII; and while SII function is essential
for productive transcription elongation, its function at this
step is critically dependent upon p300-dependent acetyla-
tion. These highly synergistic transcriptional elongation ac-
tivities on chromatin templates are potentiated byHMGB2.
SII, the Major Active Component of CTEA, Acts to
Overcome the Nucleosome Block to Activator/
Coactivator-Dependent Transcription by RNA
Polymerase II
Our finding that SII is the major active component of CTEA
has strong support from earlier biochemical and genetic
analyzes. In vitro studies have shown that SII effects
transcription elongation by inducing RNA polymerase II-282 Cell 125, 275–286, April 21, 2006 ª2006 Elsevier Inc.mediated cleavage of nascent RNA, a step required to
overcome transcription arrest caused by some DNA se-
quences (Fish and Kane, 2002; Wind and Reines, 2000).
Structural studies show that SII remodels the active site
of RNA polymerase II through interactions of domains II
and III, respectively, with the RPB1/RPB9 jaw and the
pore and active site of RNA polymerase II (Kettenberger
et al., 2003). The antiarrest function of SII was identified
during in vitro transcription analyses of DNA templates
that contain natural gene sequences implicated in RNA
polymerase II arrest (Fish and Kane, 2002; Wind and Re-
ines, 2000). It also has been shown that both SII and the
RNA polymerase subunit RPB9 are required for RNA poly-
merase II to overcome transcription arrest (Awrey et al.,
1997). In addition, studies in yeast have shown that, under
certain conditions such as growth in 6-azauracil (which
depletes the GTP or UTP pool) or mutations in other fac-
tors, the absence of SII is often associated with defects
in transcription elongation. As further evidence of SII in-
volvement in RNA polymerase II transcription in vivo, other
studies have indicated genetic interactions between SII
and components of the ATP-dependent chromatin re-
modeling complex SWI-SNF (Davie and Kane, 2000), as
well as other elongation factors such as Spt4-Spt5, the
Paf1 complex, Elongator, and FACT (Arndt and Kane,
2003; Sims et al., 2004). Perhaps more important are ob-
servations that there is a strong genetic interaction be-
tween SII and the RNA polymerase II subunits and that
SII-induced transcript cleavage is critical for survival of
yeast in the context of RPB mutants (Hartzog et al.,
1998; Lennon et al., 1998; Malagon et al., 2004; Ubukata
et al., 2003; Wery et al., 2004). Further indicative of an
SII role in elongation is its specific association with elon-
gating RNA polymerase II in open reading frames, but
not at promoters, of induced genes (Adelman et al.,
2005; Pokholok et al., 2002).
With respect to an SII effect on chromatin-templated
transcription, an earlier study using a crude chromatin as-
sembly system and a purified elongation complex showed
a modest stimulatory effect of SII in overcoming a nucleo-
some-imposed block to elongating RNA polymerase (Iz-
ban and Luse, 1992). A later study from the same group
failed to reproduce this effect, but this may have reflected
the use of chromatin assembled with purified histones by
salt dialysis and the absence of any ATP-dependent chro-
matin-remodeling factor (Chang and Luse, 1997). None-
theless, and while this manuscript was in preparation, Kir-
eeva et al. (2005) reported that a ‘‘minimal’’ yeast RNA
polymerase II elongation complex, artificially constructed
with a short RNA primer-annealed DNA and ligated to
a single nucleosome, is incapable of overcoming a single
nucleosome block during transcription and that RNA poly-
merase II arrest is followed by a backtracking process that
can be relieved by the addition of recombinant SII. This
study is relevant since it shows that backtracking also oc-
curs when RNA polymerase II encounters a nucleosome
and that SII, or agents that prevent backtracking, can
overcome the block (Kireeva et al., 2005).
In contrast to the work of Kireeva et al., the present
study describes an unbiased isolation, from transcrip-
tion-competent HeLa nuclear extract, of major compo-
nents that facilitate activator- and coactivator-dependent
transcription by RNA polymerase II through several nucleo-
somes on a chromatin template. One of the isolated
components is transcription elongation factor SII, a major
active component of CTEA activity that is able to potenti-
ate activator-dependent transcription from a chromatin
template in a highly purified transcription system that is
also dependent on both p300 and acetyl-CoA. Most im-
portantly, and in the context of this more physiological as-
say system, we have shown (1) that SII function is required
during the productive transcription elongation step, but
not during transcription initiation or promoter clearance,
and (2) that SII and p300 (via histone acetylation) act in
a highly synergistic fashion at a step subsequent to preini-
tiation complex assembly. This analysis also provides the
first demonstration that the broadly used coactivator p300
(and histone acetylation) necessarily acts at a step (elon-
gation) subsequent to PIC formation, as opposed to
having a selective role in PIC formation. The previous
demonstration (An et al., 2002; Ito et al., 2000) that
p300-dependent acetylation of histones in ACF-assem-
bled chromatin depends upon ACF makes it likely that
ATP-dependent chromatin remodeling (by ACF) is also re-
quired in the present study. Importantly, in the same puri-
fied system, SII is not required for activator-dependent
transcription from DNA templates, indicative of an impor-
tant and specific SII role in transcription from natural chro-
matin templates. Also indicative of an apparent general
role of SII in activator-dependent chromatin transcription,
SII has been shown to act with different activators that in-
clude NF-kB (p50/p65), Sp1, GAL4p65, GAL4VP16, and
GAL4p53. Consistent with its previously demonstrated
function as an elongation factor in model (activator-inde-pendent) systems, the present study shows that SII and
p300 plus acetyl-CoA also act at the elongation step to al-
low RNA polymerase II to transcribe through several con-
tiguous nucleosomes, in response to activators.
Finally, we have found that HMGB2, while showing no
coactivator activity on its own, can potentiate the activity
of the major active component, SII, of CTEA together
with p300 plus acetyl-CoA and that it acts mainly at the
level of elongation. This is an important finding in light of
the fact that HMGB2, like its closely related paralog
HMGB1, is a prominent nonhistone chromatin-associated
protein (Bustin, 2001). Several roles have been proposed
for HMGB1 and HMGB2 proteins, including architectural
and chaperone roles (Thomas, 2001). SomeHMGB2 coac-
tivator function on a histone-free DNA template in a semi-
purified transcription system has been reported earlier
(Shykind et al., 1995). However, our demonstration that
HMGB2 potentiates chromatin transcription is likely to be
of greater significance since this is a bona fide chroma-
tin-associated protein. The close structural similarity be-
tween the ubiquitous HMGB1 and the tissue-restricted
HMGB2 suggests that both will have a similar function;
and whereas SII has a potent activity on its own in the un-
folded chromatin template employed here, the HMGB2
stimulatory effect observed here could assume greater sig-
nificance in vivo on more physiological (e.g., constrained)
templates and at potentially limiting concentrations of SII.
Relationship of SII to Other Elongation Factors
that Facilitate Chromatin Transcription
Using biochemical and genetic approaches, several fac-
tors in addition toSII havebeen shown toplay a role in tran-
scription elongation. They include, but are not restricted to,
TFIIF, ELL, Spt6, Spt4-Spt5 (DSIF), NELF, the Paf1 com-
plex, Elongator, and FACT (Shilatifard et al., 2003; Sims
et al., 2004). Among these factors, FACT has been shown
to facilitate transcription through nucleosomes in vitro (Or-
phanides et al., 1998) and is composed of Spt16 and
SSRP1 proteins (Orphanides et al., 1999). Genetic studies
in yeast have implicated Spt16 in transcription regulation
(Belotserkovskaya et al., 2004), whereas biochemical
studies have shown that mammalian FACT has a histone
chaperone activity and acts by destabilizing nucleosome
structure during passage by RNA polymerase II (Belotser-
kovskaya et al., 2003).
Givenademonstrated requirementof FACT inpromoting
activator (GAL4VP16)-dependent transcription by RNA
polymerase II through 2 nucleosomes (390 nucleotide tran-
script) in a well-defined reconstituted system (Orphanides
et al., 1998), with no apparent requirement for (or effect
of) SII, it is important to considerwhySII functions in theab-
sence of FACT in the present study and in that of Kireeva
et al. (2005). Several points are relevant. First, the assay
system utilized by the investigators (LeRoy et al., 1998;
Orphanides et al., 1998) contained S190-assembled/puri-
fied chromatin, purified RNA polymerase II and GTFs, and
PC4. Notably, it did not contain Mediator and a histone
modifying coactivator such as p300, which we found toCell 125, 275–286, April 21, 2006 ª2006 Elsevier Inc. 283
be essential for high levels of activator-dependent tran-
scription fromDNA and chromatin templates, respectively.
Hence, the activity observed by Orphanides et al. (1998)
may be a minor component of that in the present study. It
is also possible that the S190-assembled chromatin con-
tained associated S190-derived SII. Second, FACT is well
characterized as a chaperone that facilitates removal of
the H2A:H2B dimer during transcription-induced nucleo-
some disassembly and (through SSRP1) may also interact
with the (H3:H4)2 tetramer (Belotserkovskaya et al., 2003).
However, while our system does not contain (or require)
FACT, it retains the ACF and NAP1 components that
were used initially for chromatin assembly. Hence, given
thewell-documented role of NAP1 as anH2A:H2B chaper-
one (Ito et al., 2000) and indications that it interacts with
(H3:H4)2 as well (reviewed in McBryant et al. [2003]), it is
probable that NAP1 can also serve as an effective chaper-
one during the transcription reaction. In support of this
view, others have shown NAP1-enhanced release of
H2A:H2B from nucleosomes during transcription (Lev-
chenko et al., 2005; Levchenko and Jackson, 2004) and,
especially relevant to our p300-dependent transcription
system, that p300-mediated acetylation facilitates transfer
of H2A:H2B dimers from nucleosomal templates to NAP1
(Ito et al., 2000). These observations support the view that
NAP1 may bypass any requirement for FACT in our assay
system but do not argue against a normal role for FACT in
the absence of other H2A:H2B chaperones or in a more
physiological setting. Our results nonetheless demonstrate
a clear SII requirement for activator-, ACF/NAP1-, and
p300/acetyl-CoA-dependent transcription fromchromatin.
Finally, It remains to be determined if some of these
components such as SII, CTEA, FACT, and/or histone-
modifying enzymes can work in a redundant, synergistic,
and/or selective manner to promote transcription of chro-
matin templates in vitro. In this regard, it is interesting to
note that, unlike SII, which thus far has specific functions
in transcription elongation, FACT has been implicated in
both transcription and replication and possibly in DNA-
damage repair and recombination as well (Belotserkov-
skaya et al., 2004).
EXPERIMENTAL PROCEDURES
Chromatin Assembly
HeLa core histones were purified from HeLa nuclear pellet as de-
scribed (Kundu et al., 2000). Recombinant histone octamers were pre-
pared as described (An et al., 2002). FLAG-Acf1, FLAG-ISWI, FLAG-
Topo 1, and FLAG-p300 were expressed in Sf9 cells and purified using
M2 agarose (Guermah et al., 2001). Histidine-tagged NAP1 (Kundu
et al., 2000) was expressed in bacteria and purified on Ni-NTA and Q
Sepharose columns. Chromatin assembly was on pG5MLD53,
pG5HML, and pHIV plasmids essentially as described (Ito et al.,
1999). Assembled chromatin was characterized by MNase analysis
as in Figures 1D and 3D.
Purification of CTEA Activity
CTEA was purified from HeLa nuclear as outlined in Figure 3C. Follow-
ing P11 chromatography, CTEA activity was found in the BC100 (100
mM KCl) eluate from DE52 and in the 0.5 M KCl eluate from Heparin284 Cell 125, 275–286, April 21, 2006 ª2006 Elsevier Inc.Sepharose. CTEA activity was further purified on Mono S and Mono
Q (FPLC) columns. The 0.1 M Mono Q flowthrough, containing CTEA
activity, was concentrated, equilibrated to 0.2 M KCl/0.02% NP-40,
and loaded on a Superose 6 (FPLC) column that was run in BC200/
0.02% NP-40.
Mass Spectrometry
Mass spectrometry was used to identify the p38 and p50 proteins in
the purified CTEA activity (Superose 6, concentrated fractions 40
and 41) and the p29 protein in the SII-enhancing activity (Mono Q frac-
tion 44) essentially as described (Krutchinsky et al., 2001; Tackett
et al., 2005).
Purification of Recombinant SII (rSII)
Recombinant mammalian SII was expressed in bacteria and purified
on Ni-NTA and a subsequent HiTrap SP column (Szentirmay and
Sawadogo, 1993).
In Vitro RNA Polymerase II Transcription Assays
Nuclear extracts (NE)werepreparedasdescribed (Dignamet al., 1983).
TFIID, TFIIH, and theMediator complex were purified from cell lines ex-
pressing FLAG-TBP, FLAG-ERCC3, and FLAG-TRAP220/Med1 (AB1),
respectively, on phosphocellulose (Whatman P11), DEAE-cellulose
(DE52), and anti-FLAG M2 agarose antibody columns (Ge et al.,
2002; Guermah et al., 2001). RNA polymerase II was purified from
nuclear pellet of a HeLa cell line expressing the FLAG-RPB9 subunit,
essentially as described (Guermah et al., 2001) but with addition of an
M2 agarose affinity step at the end.
TFIIA subunits (p55 and p12), TFIIB, and TFIIE subunits (a and b)
were expressed as FLAG- tagged proteins in E. coli and purified on
M2 agarose. TFIIF subunits (RAP30 and RAP74) were expressed as
histidine-tagged proteins in E. coli and purified on Ni-NTA. TFIIA and
TFIIF were reconstituted from individually purified components follow-
ing denaturation and renaturation (Guermah et al., 2001). Native TFIIA,
purified through several columns (Guermah et al., 1998), was used in
experiment described in Figure 3E.
FLAG-GAL4p65 (fGAL4p65), FLAG-GAL4VP16 (fGAL4VP16), and
FLAG-GAL4p53 (fGAL4p53) were purified as described (Guermah
et al., 1998). FLAG-Sp1 and NF-kB (p65/p50) were purified from Sf9
cells as described (Guermah et al., 1998), except that a FLAG-p65 sub-
unit was used instead of a histidine-tagged p65 subunit.
Transcription assays with the reconstituted system (GTFs, RNA
polymerase II, PC4, and Mediator) were performed as described
(Guermah et al., 2001; Kundu et al., 2000), except that PC4 was omit-
ted from the assays used during the purification of CTEA. Reconsti-
tuted chromatin templates (35 ng DNA) or equivalent amounts of his-
tone-free DNA were incubated with activators for binding, followed
by a p300 acetylation step in the presence of 2 mM acetyl-CoA
(AcCoA). An active CTEA fraction or recombinant SII then was added,
followed by the general transcriptionmachinery described above. Tran-
scription assays for 12- and 21-nucleotide transcripts used pG5HML
plasmids with corresponding G-less cassettes (Fukuda et al., 2002).
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